Technology
Health
Therapy

Neoleukin Therapeutics

$11.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.29 (-2.54%) As of 3:32 PM EDT today

Why Robinhood?

You can buy or sell NLTX and other stocks, options, ETFs, and crypto commission-free!

About NLTX

Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Read More Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. The listed name for NLTX is Neoleukin Therapeutics, Inc. Common Stock.

CEO
Jonathan G. Drachman
Employees
36
Headquarters
Seattle, Washington
Founded
2003
Market Cap
473.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
240.86K
High Today
$11.89
Low Today
$11.00
Open Price
$11.69
Volume
150.70K
52 Week High
$18.13
52 Week Low
$2.53

Collections

Technology
Health
Therapy
Biopharmaceutical
Medical
Pharmaceutical
2014 IPO
US

NLTX Earnings

-$0.44
-$0.29
-$0.15
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 11, After Hours

You May Also Like

VER
EMSH
MMX
DCOM
ZYNE
PWS
PGM
MNP
EWCO
SPDN
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.
Buy NLTX
Market Price
$11.32
Commissions
$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell NLTX stock and options commission-free.
LearnBlogCareersHelpLog InSign Up